Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 89895-55-6 | MDL No. : | MFCD01861791 |
Formula : | C7H14ClNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BQQZKNAQDKIGGZ-UHFFFAOYSA-N |
M.W : | 179.64 | Pubchem ID : | 16336093 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.62 |
TPSA : | 38.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.03 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.52 |
Log Po/w (WLOGP) : | 0.58 |
Log Po/w (MLOGP) : | 0.69 |
Log Po/w (SILICOS-IT) : | 0.9 |
Consensus Log Po/w : | 0.54 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.15 |
Solubility : | 12.7 mg/ml ; 0.0709 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.9 |
Solubility : | 22.8 mg/ml ; 0.127 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.14 |
Solubility : | 13.0 mg/ml ; 0.0723 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 50585-89-2 ]
Methyl piperidine-3-carboxylate
Similarity: 0.97
[ 37675-19-7 ]
(R)-Ethyl piperidine-3-carboxylate hydrochloride
Similarity: 0.95
[ 4842-86-8 ]
Ethyl 3-piperidinecarboxylate hydrochloride
Similarity: 0.95
[ 176523-95-8 ]
Ethyl 3-methylpiperidine-3-carboxylate hydrochloride
Similarity: 0.93
[ 25137-01-3 ]
(R)-Ethyl piperidine-3-carboxylate
Similarity: 0.93
[ 50585-89-2 ]
Methyl piperidine-3-carboxylate
Similarity: 0.97
[ 37675-19-7 ]
(R)-Ethyl piperidine-3-carboxylate hydrochloride
Similarity: 0.95
[ 4842-86-8 ]
Ethyl 3-piperidinecarboxylate hydrochloride
Similarity: 0.95
[ 176523-95-8 ]
Ethyl 3-methylpiperidine-3-carboxylate hydrochloride
Similarity: 0.93
[ 25137-01-3 ]
(R)-Ethyl piperidine-3-carboxylate
Similarity: 0.93
[ 50585-89-2 ]
Methyl piperidine-3-carboxylate
Similarity: 0.97
[ 37675-19-7 ]
(R)-Ethyl piperidine-3-carboxylate hydrochloride
Similarity: 0.95
[ 4842-86-8 ]
Ethyl 3-piperidinecarboxylate hydrochloride
Similarity: 0.95
[ 176523-95-8 ]
Ethyl 3-methylpiperidine-3-carboxylate hydrochloride
Similarity: 0.93
[ 25137-01-3 ]
(R)-Ethyl piperidine-3-carboxylate
Similarity: 0.93